icon-folder.gif   Conference Reports for NATAP  
 
  ID Week 2024
October 16-19
Los Angeles, California

 Back grey_arrow_rt.gif
 
 
 
Long-Acting Subcutaneous Lenacapavir in People with HIV-1 Multi-Drug Resistant HIV-1: 3-Year Results of the CAPELLA Study
 
 
 

1020241

1020242

1020243

1020244

1020245

1020246